Abstract
Eye tracking is one of the emerging techniques clinicians use to establish the presence and monitor the progression of neurodegenerative disorders (NDs). The clinical observation and assessment of extra-ocular movements is common practice to detect motoric and cognitive impairments but remains observer-dependent and subjective. In the present study, we propose an algorithm that can automatically identify saccades, fixation, smooth pursuit, and blinks using a non-invasive eye-tracker and, subsequently, extract response-to-stimuli-derived interpretable features that objectively assess patient behaviors. The cohort analysis encompasses control subjects (CTRL) and persons with Alzheimer’s disease (AD) or Mild Cognitive Impairment (MCI), Parkinson’s disease (PD), and Parkinson’s disease mimics (PDM). Overall, results suggested that the control group had significantly longer smooth pursuit distance (p < 0.05) in contrast to other cohorts. Additionally, the average hypometria prosaccade gain was significantly smaller (p < 0.05) for PD and AD/MCI relative to CTRL. The number of omitted saccades relative to a presented stimulus in the antisaccade task and latency were significantly greater (p < 0.05) for PD and AD/MCI compared to CTRL. These features, as oculographic biomarkers, can be potentially leveraged in distinguishing different types of neurodegenerative disorders in their early stages, yielding more objective and precise protocols to monitor disease progression.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Richman Family PMCoE-AD Venture Discovery Fund and Consolidated Anti-Aging Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants underwent informed consent. The IRB of Johns Hopkins Medicine gave ethical approval for the data collection and this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The authors plan to share all data produced in the present study in the future.
